2644 related articles for article (PubMed ID: 22122739)
21. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
Odisho AY; Berry AB; Ahmad AE; Cooperberg MR; Carroll PR; Konety BR
Eur Urol; 2013 May; 63(5):936-40. PubMed ID: 22521093
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic tests in urology: urine cytology.
Lavallée LT; Fergusson D; Dahm P; Scales CD; Witiuk K; Breau RH
BJU Int; 2012 Dec; 110(11 Pt C):E789-91. PubMed ID: 23106855
[TBL] [Abstract][Full Text] [Related]
23. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
24. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
25. The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office.
Devlies W; de Jong JJ; Hofmann F; Bruins HM; Zuiverloon TCM; Smith EJ; Yuan Y; van Rhijn BWG; Mostafid H; Santesso N; Violette P; Omar MI
Eur Urol Focus; 2024 Jan; 10(1):115-122. PubMed ID: 37633791
[TBL] [Abstract][Full Text] [Related]
26. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results.
Trinh TW; Glazer DI; Sadow CA; Sahni VA; Geller NL; Silverman SG
Abdom Radiol (NY); 2018 Mar; 43(3):663-671. PubMed ID: 28677000
[TBL] [Abstract][Full Text] [Related]
27. Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment.
Nurminen P; Ettala O; Seppänen M; Taimen P; Boström PJ; Kaipia A
BJU Int; 2019 Feb; 123(2):246-251. PubMed ID: 29959824
[TBL] [Abstract][Full Text] [Related]
28. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
[TBL] [Abstract][Full Text] [Related]
29. Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
Valenberg FJPV; Hiar AM; Wallace E; Bridge JA; Mayne DJ; Beqaj S; Sexton WJ; Lotan Y; Weizer AZ; Jansz GK; Stenzl A; Danella JF; Cline KJ; Williams MB; Montgomery S; David RD; Harris R; Klein EW; Bradford TJ; Wolk FN; Westenfelder KR; Trainer AF; Richardson TA; Egerdie RB; Goldfarb B; Zadra JA; Lu X; Simon IM; Campbell SA; Bates MP; Higuchi RG; Witjes JA
Eur Urol Oncol; 2021 Feb; 4(1):93-101. PubMed ID: 33004290
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
32. Bladder cancer diagnosis: the role of CT urography.
Capalbo E; Kluzer A; Peli M; Cosentino M; Berti E; Cariati M
Tumori; 2015; 101(4):412-7. PubMed ID: 25953449
[TBL] [Abstract][Full Text] [Related]
33. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
Raitanen MP; Aine R; Kylmälä T; Kallio J; Liukkonen T; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413
[TBL] [Abstract][Full Text] [Related]
34. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
[TBL] [Abstract][Full Text] [Related]
35. Split-bolus MDCT urography with synchronous nephrographic and excretory phase enhancement.
Chow LC; Kwan SW; Olcott EW; Sommer G
AJR Am J Roentgenol; 2007 Aug; 189(2):314-22. PubMed ID: 17646456
[TBL] [Abstract][Full Text] [Related]
36. [Clinical usefulness of the ImmunoCyt urinary test in the follow-up protocol of patients with urothelial neoplasms].
García Peñalver C; Pérez Barrios A; Leiva Galvis O
Actas Urol Esp; 2005 Jun; 29(6):535-41. PubMed ID: 16092675
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
[TBL] [Abstract][Full Text] [Related]
38. Human complement factor H related protein test for monitoring bladder cancer.
Raitanen MP; Marttila T; Nurmi M; Ala-Opas M; Nieminen P; Aine R; Tammela TL;
J Urol; 2001 Feb; 165(2):374-7. PubMed ID: 11176376
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
Leyh H; Hall R; Mazeman E; Blumenstein BA
Urology; 1997 Jul; 50(1):49-53. PubMed ID: 9218018
[TBL] [Abstract][Full Text] [Related]
40. [NMP-22 test. Is it useful in the follow-up of patients with superficial bladder tumor?].
Pérez García FJ; Eyo A; Escaf Barmadah S; Fernández Gómez JM
Arch Esp Urol; 2002 Dec; 55(10):1201-8. PubMed ID: 12611217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
